Harbor Investment Advisory LLC Has $30,000 Position in Palantir Technologies Inc. (NYSE:PLTR)

Harbor Investment Advisory LLC cut its stake in shares of Palantir Technologies Inc. (NYSE:PLTR – Get Rating) by 80.6% during the 2nd quarter, Holdings Channel reports. The fund owned 3,300 shares of the company’s stock after selling 13,750 shares during the period. Harbor Investment Advisory LLC’s holdings in Palantir Technologies were worth $30,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. IndexIQ Advisors LLC bought a new position in shares of Palantir Technologies during the 1st quarter worth $27,000. Endurance Wealth Management Inc. bought a new position in Palantir Technologies during the first quarter worth about $27,000. Herold Advisors Inc. purchased a new position in shares of Palantir Technologies in the first quarter worth about $35,000. TCI Wealth Advisors Inc. raised its position in shares of Palantir Technologies by 58.5% in the first quarter. TCI Wealth Advisors Inc. now owns 2,820 shares of the company’s stock valued at $39,000 after purchasing an additional 1,041 shares during the period. Finally, UMB Bank NA MO lifted its stake in shares of Palantir Technologies by 58.6% during the 1st quarter. UMB Bank NA MO now owns 3,240 shares of

Pressure Technologies (LON:PRES) Shares Cross Below 50 Day Moving Average of $71.60

Pressure Technologies plc (LON:PRES – Get Rating)’s stock price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 71.60 ($0.87) and traded as low as GBX 65 ($0.79). Pressure Technologies shares last traded at GBX 66.50 ($0.80), with a volume of 9,635 shares traded.

Pressure Technologies Stock Down 1.5%

The stock has a 50-day moving average of GBX 71.60 and a two-hundred day moving average of GBX 79.34. The company has a market cap of £20.66 million and a P/E ratio of -5.54. The company has a debt-to-equity ratio of 44.16, a quick ratio of 1.24 and a current ratio of 1.73.

Pressure Technologies Company Profile

(Get Rating)

Pressure Technologies plc, through its subsidiaries, designs and manufactures high pressure components and systems for the oil and gas, defense, industrial gases, and hydrogen energy markets in the United Kingdom, Europe, and internationally. It operates through two segments, Cylinders and Precision Machined Components.

Read More

Receive News & Ratings for Pressure Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Pressure Technologies and related companies with

Dynavax Technologies (NASDAQ:DVAX) Cut to C+ at TheStreet

TheStreet cut shares of Dynavax Technologies (NASDAQ:DVAX – Get Rating) from a b- rating to a c+ rating in a report released on Thursday morning, TheStreetRatingsTable reports.

Separately, StockNews.com upgraded Dynavax Technologies from a hold rating to a buy rating in a report on Friday, August 5th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus price target of $28.00.

Dynavax Technologies Stock Performance

Dynavax Technologies stock opened at $11.21 on Thursday. The stock’s 50-day moving average is $13.86 and its 200-day moving average is $11.89. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 8.01 and a beta of 1.30. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.77 and a quick ratio of 2.55. Dynavax Technologies has a 12 month low of $7.26 and a 12 month high of $21.39.

Insider Activity at Dynavax Technologies

Want More Great Investing Ideas?

In related news, SVP Robert Janssen sold 7,938 shares of the firm’s stock in a transaction dated Tuesday, August 9th.

Cyxtera Technologies (NASDAQ:CYXT) Hits New 1-Year Low at $7.14

Shares of Cyxtera Technologies, Inc. (NASDAQ:CYXT – Get Rating) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $7.14 and last traded at $7.18, with a volume of 4431 shares traded. The stock had previously closed at $7.25.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CYXT. Citigroup upgraded shares of Cyxtera Technologies from a “neutral” rating to a “buy” rating and set a $13.00 target price on the stock in a report on Wednesday. Credit Suisse Group dropped their target price on shares of Cyxtera Technologies to $13.00 in a report on Monday, August 15th. Truist Financial lifted their price target on shares of Cyxtera Technologies from $15.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, June 8th. Finally, Royal Bank of Canada lifted their price target on shares of Cyxtera Technologies from $14.00 to $16.00 in a research note on Monday, June 6th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”

SolarEdge Applied sciences, Inc. (NASDAQ:SEDG) Receives Consensus Advice of “Reasonable Purchase” from Analysts

Shares of SolarEdge Applied sciences, Inc. (NASDAQ:SEDG – Get Ranking) have earned a consensus suggestion of “Maintain” from the twenty-eight brokerages which can be at present masking the inventory, Marketbeat studies. Two analysts have rated the inventory with a promote suggestion, seven have issued a maintain suggestion and twelve have given a purchase suggestion to the corporate. The common twelve-month worth goal amongst analysts which have issued scores on the inventory within the final 12 months is $358.24.

SEDG has been the subject of plenty of latest analyst studies. Guggenheim upped their goal worth on SolarEdge Applied sciences from $348.00 to $389.00 in a analysis report on Wednesday, August third. JPMorgan Chase & Co. lifted their worth goal on shares of SolarEdge Applied sciences from $373.00 to $419.00 and gave the corporate an “obese” ranking in a analysis report on Monday, August eighth. TheStreet upgraded shares of SolarEdge Applied sciences from a “c” ranking to a “b-” ranking in a analysis report on Tuesday, August 2nd. Citigroup boosted their worth goal on shares of SolarEdge Applied sciences from $255.00 to $300.00 and gave the inventory a “maintain” ranking in a analysis report on Tuesday, Could third. Lastly, Morgan Stanley lowered

Copperleaf Applied sciences (TSE:CPLF) Inventory Worth Down 0.1%

Copperleaf Applied sciences Inc. (TSE:CPLF – Get Score) shares fell 0.1% throughout buying and selling on Tuesday . The corporate traded as little as C$6.84 and final traded at C$7.09. 38,618 shares modified fingers throughout mid-day buying and selling, a decline of 44% from the common session quantity of 69.094 shares. The inventory had beforehand closed at C$7.10.

Analyst Upgrades and Downgrades

Plenty of brokerages have lately commented on CPLF. CIBC dropped their value goal on Copperleaf Applied sciences from C$18.00 to C$11.00 and set a “impartial” score on the inventory in a analysis report on Thursday, Could twelfth. BMO Capital Markets decreased their goal value on shares of Copperleaf Applied sciences from C$20.00 to C$15.00 in a analysis word on Thursday, Could twelfth. Cormark decreased their goal value on shares of Copperleaf Applied sciences from C$25.00 to C$16.00 and set a “scale back” score for the corporate in a analysis word on Wednesday, Could eleventh. Lastly, Nationwide Bankshares decreased their goal value on shares of Copperleaf Applied sciences from C$20.00 to C$16.00 and set an “outperform” score for the corporate in a analysis word on Thursday, Could twelfth.

Copperleaf Applied sciences Buying and selling Down 0.1 %

The inventory

Critics say short-staffed pressing main care facilities are failing

Authorities has put a forms in cost as a substitute of medical doctors, critics cost

Article content material

Outcry is rising over the BC authorities’s chronically understaffed pressing and first care clinics, which critics say are tormented by an inefficient and dear forms and a system that does nothing to draw household medical doctors.

Commercial 2

Article content material

This week, the BC Liberals known as for an audit to handle the “worsening dysfunction” of the pressing main care clinics, whereas the BC Greens beneficial maintaining the clinic infrastructure however giving management again to the medical doctors.

A Chilliwack physician on Wednesday joined the refrain of criticism, calling for the federal government to supply funding on to medical doctors to ascertain team-based main care clinics

Analysis Analysts Provide Predictions for Procore Applied sciences, Inc.’s Q2 2022 Earnings (NASDAQ:PCOR)

Procore Applied sciences, Inc. (NASDAQ:PCOR – Get Ranking) – Equities researchers at Oppenheimer issued their Q2 2022 EPS estimates for Procore Applied sciences in a analysis notice issued to traders on Wednesday, July twenty seventh. Oppenheimer analyst Ok. Wong anticipates that the corporate will submit earnings of ($0.46) per share for the quarter. Oppenheimer has a “Assumes” score on the inventory. The consensus estimate for Procore Applied sciences’ present full-year earnings is ($1.81) per share. Oppenheimer additionally issued estimates for Procore Applied sciences’ Q3 2022 earnings at ($0.48) EPS, This autumn 2022 earnings at ($0.49) EPS, FY2022 earnings at ($1.85) EPS, FY2023 earnings at ($1.83) EPS and FY2024 earnings at ($1.65) EPS.

A number of different analysts have additionally just lately weighed in on PCOR. JPMorgan Chase & Co. dropped their value goal on Procore Applied sciences from $113.00 to $95.00 in a report on Thursday, June sixteenth. The Goldman Sachs Group dropped their value goal on Procore Applied sciences from $90.00 to $77.00 and set a “impartial” score for the corporate in a report on Thursday, April 14th. Jefferies Monetary Group dropped their value goal on Procore Applied sciences from $90.00 to $75.00 in a report on Monday, Might

Studying Applied sciences Group (LON:LTG) Share Worth Passes Above 50-Day Transferring Common of $119.95

Studying Applied sciences Group plc (LON:LTG – Get Score) crossed above its 50-day shifting common throughout buying and selling on Tuesday . The inventory has a 50-day shifting common of GBX 119.95 ($1.43) and traded as excessive as GBX 122.30 ($1.46). Studying Applied sciences Group shares final traded at GBX 121.50 ($1.45), with a quantity of 834,615 shares.

Analyst Upgrades and Downgrades

Various equities analysis analysts have lately commented on the inventory. Canaccord Genuity Group lowered their value goal on shares of Studying Applied sciences Group from GBX 180 ($2.15) to GBX 165 ($1.97) and set a “maintain” ranking for the corporate in a report on Thursday, Might fifth. Berenberg Financial institution lowered their value goal on shares of Studying Applied sciences Group from GBX 250 ($2.99) to GBX 200 ($2.39) and set a “purchase” ranking for the corporate in a report on Friday, Might twentieth.

Studying Applied sciences Group Buying and selling Up 0.4%

The enterprise’s fifty day shifting common is GBX 119.95 and its 200-day shifting common is GBX 145.85. The inventory has a market capitalization of £957.69 million and a PE ratio of 6,075.00. The corporate has a fast ratio of 1.10, a present ratio of 1.17